Received May 6, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | Y013818 | OT / RA |
No additional AE; improperly stored AE for GARDASIL-9; This spontaneous report was received from a office menager and refers to 11-year-old female patient. The patient's medical history and concurrent conditions were not reported. Concomitant medications included meningococcal vaccine A/C/Y/W conj (tet tox) (Menquadfi) and Diphtheria vaccine toxoid; Pertussis vaccine acellular 3-component; Tetanus vaccine toxoid (BOOSTRIX). On 04-Feb-2026, the patient was vaccinated with improperly stored the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (Gardasil 9) (valid lot #Y013818, expiration date: 12-Feb-2027), administered by Intramuscular route in Right Arm as prophylaxis (product storage issue). No additional adverse event (AE) was reported,
MenQuadfi; Boostrix